PLUS Products Bolsters Research Expertise with the Addition of Chief Scientific Officer Dr. Ari Mackler
SAN MATEO, Calif., Oct. 21, 2019 (GLOBE NEWSWIRE) — Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) (the “Company” or “PLUS”) […]
Golar LNG Limited – Q3 2019 results presentation
Golar LNG’s 3rd Quarter 2019 results will be released before the NASDAQ opens on Tuesday November 26, 2019. In connection […]
Dr. Mark H. Pollack named Chief Medical Officer for Myriad Neuroscience
SALT LAKE CITY, Oct. 21, 2019 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and […]
Manhattan Bridge Capital, Inc. Reports Third Quarter 2019 Results
GREAT NECK, N.Y., Oct. 21, 2019 (GLOBE NEWSWIRE) —Manhattan Bridge Capital, Inc. (Nasdaq: LOAN) announced today that total revenue for […]
Teradyne to Acquire AutoGuide Mobile Robots
AutoGuide offers uniquely modular autonomous mobile tuggers and forklifts for high-payload material transport of up to 10,000 pounds (4,500 kg).Autonomous […]
Axsome Therapeutics Completes Patient Enrollment in the CONCERT Phase 2 Trial of AXS-12 in Narcolepsy
NEW YORK, Oct. 21, 2019 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies […]
Idera Pharmaceuticals Announces New U.S. Patent For Tilsotolimod Through September 2037
EXTON, Pa., Oct. 21, 2019 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), or the Company, announced today that the […]
AGTC Presents Data Demonstrating Efficiency of its AAV Vectors for Ocular Gene Therapy Even in the Presence of Anti-AAV Antibodies
–Data support safety and potential clinical utility of AGTC’s ocular gene therapy candidates regardless of patients’ AAV antibody status-GAINESVILLE, Fla., […]
DSP Group Inc.’s Third Quarter 2019 Earnings Release and Conference Call
SAN JOSE, Calif., Oct. 21, 2019 (GLOBE NEWSWIRE) — DSP Group® Inc. (NASDAQ:DSPG), will release its earnings results for the […]
GLP-1 Analogue Delivered Robustly via Subcutaneous Infusion with Valeritas Proprietary h-Patch™ Wearable Device in Preclinical Study
BRIDGEWATER, N.J., Oct. 21, 2019 (GLOBE NEWSWIRE) — Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of […]
